These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2849033)

  • 1. The calcium antagonist drugs.
    Nayler WG
    Med J Aust; 1988 Dec 5-19; 149(11-12):682-6. PubMed ID: 2849033
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium channel ligands.
    Triggle DJ; Janis RA
    Annu Rev Pharmacol Toxicol; 1987; 27():347-69. PubMed ID: 3034140
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium antagonist receptors.
    Reynolds IJ; Snyder SH
    Ion Channels; 1988; 1():213-49. PubMed ID: 2856492
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis and functional characteristics of dihydropyridine-sensitive and -insensitive calcium channel proteins.
    Dascal N
    Biochem Pharmacol; 1990 Sep; 40(6):1171-8. PubMed ID: 2169741
    [No Abstract]   [Full Text] [Related]  

  • 5. Increasing complexity revealed in regulation of Ca2+ antagonist receptor.
    Godfraind T; Govoni S
    Trends Pharmacol Sci; 1989 Aug; 10(8):297-301. PubMed ID: 2555941
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemistry, molecular pharmacology, and functional control of Ca2+ channels.
    Barhanin J; Borsotto M; Coppola T; Fosset M; Hosey MM; Mourre C; Pauron D; Qar J; Romey G; Schmid A
    Ann N Y Acad Sci; 1989; 560():15-26. PubMed ID: 2545130
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation between the results of functional and receptor binding studies in cardiac muscle.
    Fejér E; Szeredi J; Gaál J; Körmöczy PS
    Adv Exp Med Biol; 1992; 311():391-2. PubMed ID: 1326867
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular properties of voltage-sensitive calcium channels.
    Catterall WA; Curtis BM
    Soc Gen Physiol Ser; 1987; 41():201-13. PubMed ID: 2436311
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on voltage-operated calcium channels using radioligands.
    Gould RJ; Murphy KM; Snyder SH
    Cold Spring Harb Symp Quant Biol; 1983; 48 Pt 1():355-62. PubMed ID: 6327164
    [No Abstract]   [Full Text] [Related]  

  • 10. Receptors for calcium antagonists.
    Schwartz A; McKenna E; Vaghy PL
    Am J Cardiol; 1988 Oct; 62(11):3G-6G. PubMed ID: 2845766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary structure of the beta subunit of the DHP-sensitive calcium channel from skeletal muscle.
    Ruth P; Röhrkasten A; Biel M; Bosse E; Regulla S; Meyer HE; Flockerzi V; Hofmann F
    Science; 1989 Sep; 245(4922):1115-8. PubMed ID: 2549640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the calcium entry blocker receptor complex in cardiac sarcolemmal membrane vesicles.
    Kaczorowski GJ; Garcia ML; King VF
    Prog Clin Biol Res; 1988; 252():29-34. PubMed ID: 2450371
    [No Abstract]   [Full Text] [Related]  

  • 13. Receptor sites for Ca2+ channel antagonists.
    Catterall WA; Striessnig J
    Trends Pharmacol Sci; 1992 Jun; 13(6):256-62. PubMed ID: 1321525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca2+ antagonist receptor sites on human red blood cell membranes.
    Striessnig J; Zernig G; Glossmann H
    Eur J Pharmacol; 1985 Feb; 108(3):329-30. PubMed ID: 2985404
    [No Abstract]   [Full Text] [Related]  

  • 15. Action and binding of calcium channel blockers on the putative calcium channel of synaptosomal plasma membrane from the electric organ of Narke japonica.
    Tokumaru H; Wang CY; Hirashima N; O'Hori T; Yamamoto H; Kirino Y
    Ann N Y Acad Sci; 1993 Dec; 707():410-2. PubMed ID: 9163314
    [No Abstract]   [Full Text] [Related]  

  • 16. Distinct effects of omega-toxins and various groups of Ca(2+)-entry inhibitors on nicotinic acetylcholine receptor and Ca2+ channels of chromaffin cells.
    Villarroya M; De la Fuente MT; López MG; Gandía L; García AG
    Eur J Pharmacol; 1997 Feb; 320(2-3):249-57. PubMed ID: 9059861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-antagonist receptors in cardiomyopathy.
    Lohse MJ
    N Engl J Med; 1989 Sep; 321(10):686-7. PubMed ID: 2549419
    [No Abstract]   [Full Text] [Related]  

  • 18. The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel.
    Triggle DJ; Janis RA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S949-55. PubMed ID: 6085383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modelling of the interaction of dihydropyridine drugs with their receptors.
    Höltje HD
    Prog Clin Biol Res; 1989; 291():237-41. PubMed ID: 2542977
    [No Abstract]   [Full Text] [Related]  

  • 20. Ca2+ channel block and inactivation: common molecular determinants.
    Hering S; Berjukow S; Aczél S; Timin EN
    Trends Pharmacol Sci; 1998 Nov; 19(11):439-43. PubMed ID: 9850606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.